| Literature DB >> 32423437 |
Elisabetta Caselli1,2, Chiara Fabbri3, Maria D'Accolti4,5, Irene Soffritti4,5, Cristian Bassi6, Sante Mazzacane5, Maurizio Franchi3.
Abstract
BACKGROUND: The microbiome of the oral cavity is the second-largest and diverse microbiota after the gut, harboring over 700 species of bacteria and including also fungi, viruses, and protozoa. With its diverse niches, the oral cavity is a very complex environment, where different microbes preferentially colonize different habitats. Recent data indicate that the oral microbiome has essential functions in maintaining oral and systemic health, and the emergence of 16S rRNA gene next-generation sequencing (NGS) has greatly contributed to revealing the complexity of its bacterial component. However, a detailed site-specific map of oral microorganisms (including also eukaryotes and viruses) and their relative abundance is still missing. Here, we aimed to obtain a comprehensive view of the healthy oral microbiome (HOM), including its drug-resistance features.Entities:
Keywords: Oral microbiome; Resistome; Site-specific microbiome map; Whole-genome sequencing (WGS)
Mesh:
Substances:
Year: 2020 PMID: 32423437 PMCID: PMC7236360 DOI: 10.1186/s12866-020-01801-y
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
List of inclusion and exclusion criteria for subjects enrollment in the study
| Inclusion | Exclusion |
|---|---|
• Male and female subjects • Age 18-30 years • Good general health: free of systemic diseases such as diabetes, HIV infection or genetic disorder, ongoing malignant disease of any type that could interfere with the evaluation of the study objectives • Good oral health: free of oral pathologies such as leukoplakia, erythroplakia, oral lichen planus (OLP) • Availability for the 6-month duration of the study for an assigned subject • Signed Informed Consent Form | • Pregnant or lactating women • More than 8 missing teeth (with missing teeth, accounted for by third molar extractions, teeth extracted for orthodontic purposes, teeth extracted because of trauma, or congenitally missing teeth) • Presence of orthodontic appliances • Chronic dry mouth (clinically assessed) • Significant halitosis (clinically assessed) • Periodontitis • Untreated carious lesions or oral abscesses • Current or past (within 3 months before enrolment) assumption of medications that may influence oral microbiome (corticosteroids, calcium channel blockers, systemic antibiotics). • Non-surgical and/or surgical mechanical/manual periodontal debridement within 3 months before enrolment. • Heart diseases or blood pressure alteration that requires a medication • Renal, hepatic, gastrointestinal disease that requires a medication • Diabetes • Presence of any sexually transmitted disease (STD), HIV, HCV infection • Genetic disorders potentially interfering with the evaluation of the study objectives • Chronic obstructive pulmonary disease and asthma • Neoplastic lesions or paraneoplastic syndrome; tumors or significant pathology of the soft or hard tissues of the oral cavity (such as LPO, erythroplakia, leukoplakia, candidiasis) • Current radiotherapy or chemotherapy |
Demographic and clinical features of the study population
| Subject ID n. | Teeth n. | Plaque Scorea | BOPb | OHD (Oral Hygiene Devices at home) | |
|---|---|---|---|---|---|
| Toothbrush | Interproximal device | ||||
| 1 | 29 | 52,30 | 9,77 | manual | none |
| 2 | 29 | 24,14 | 9,77 | powered | none |
| 3 | 32 | 19,79 | 8,33 | powered | floss |
| 4 | 30 | 12,22 | 2,22 | powered | none |
| 5 | 31 | 22,62 | 1,79 | manual | none |
| 6 | 28 | 23,21 | 1,19 | manual | floss |
| 7 | 30 | 20,00 | 2,78 | manual | none |
| 8 | 32 | 28,65 | 1,56 | powered | none |
| 9 | 31 | 25,27 | 5,38 | manual | none |
| 10 | 30 | 27,78 | 2,22 | powered | floss |
| 11 | 28 | 17,26 | 2,97 | powered | none |
| 12 | 30 | 22,39 | 9,89 | manual | floss |
| 13 | 28 | 30,36 | 2,98 | manual | floss |
| 14 | 32 | 27,98 | 4,17 | manual | floss |
| 15 | 28 | 8,93 | 0,60 | powered | none |
| 16 | 32 | 20,31 | 1,04 | manual | floss |
| 17 | 31 | 29,03 | 2,15 | manual | none |
| 18 | 28 | 22,02 | 4,76 | manual | floss |
| 19 | 30 | 23,89 | 2,78 | powered | floss |
| 20 | 28 | 25,00 | 3,57 | powered | none |
aPlaque Score (O’Leary PL, which represents the percentage of sites, four per tooth, presenting plaque; the optimal value should be less than 20%),
bBleeding on Probing (BOP) index (representing the percentage of sites, six per tooth, presenting bleeding on periodontal probing; the optimal value should be less than 10%)
Fig. 1Relative abundance and distribution of the microbial genera detected in the oral cavity. a Heatmap representation of genera detected by WGS analysis in each sampled site from each enrolled subject. Hierarchical legends are also shown. b Heatmap representation of genera detected by WGS analysis in the clustered different sampled sites. Hierarchical legends are also shown. c Percentage distribution of detected genera in the different sampled sites of the oral cavity. d Prevalence of viruses detected in the oral cavity: upper panel, composition of the whole oral virome; lower panels, comparison between virus species prevalence detected in saliva, oral rinse, and site-specific sampled sites (other sites: hard and soft tissues). Results are expressed as the percentage of counts of each species on the total counts of the whole oral virome in all sampled sites
Fig. 2Alpha and beta-diversity analysis of HOM in collected samples. a Alpha-diversity values in each enrolled study participant. b Alpha-diversity values in all samples grouped for the specific sampling site. c Alpha-diversity values in sub-groups of study participants, subdivided for gender (left panel) (M, male; F, female), use of an interproximal device (tooth floss or none), and use of manual or powered toothbrush. Median line, interquartile range, and min-max values for each box-plot are shown. The p value as detected by Student’s t test is also shown in panel c. d Beta-diversity, as detected by Weighted Unifrac analysis, in the different site-specific samples from all the study participants. Multidimensional scaling (MDS) analysis of Weighted Unifrac similarity index is shown
Fig. 3Heat-tree representation of the relative abundance of the detected, subdivided for sampled sites. Phyla, classes, orders, families, genera, and species are represented. Node label, taxon name; node size, number of operational taxonomic units (OTUs); node color, abundance of the indicated phylum/class/family/genus/species (from grey to green, as reported in the color scale)
Fig. 4Heatmap representing the distribution of the most 62 representative HOM microbial genera. a Results obtained in the different sampled oral sites from all the study participants (excluding saliva samples). b Mean prevalence values of the most representative 62 genera in each collection site (excluding saliva). Hierarchical legends are also shown for both panels. c Microbial genera best defining the site-specificity of the oral microbiome, as detected by PAM analysis
Cross-tabulation of true (rows) versus predicted (columns) classes for PAM fit
| ORAL SITE | Tongue | Keratinized gingiva | Oral mucosa | Hard palate | Supragingival plaque | Subgingival plaque |
|---|---|---|---|---|---|---|
| 18 | 0 | 0 | 2 | 0 | 0 | |
| 0 | 16 | 4 | 0 | 0 | 0 | |
| 0 | 2 | 18 | 0 | 0 | 0 | |
| 3 | 3 | 2 | 12 | 0 | 0 | |
| 0 | 0 | 1 | 0 | 17 | 2 | |
| 1 | 0 | 2 | 0 | 6 | 11 |
Performance of PAM classifier during cross-validation
| ORAL SITE | Sensitivity | Specificity | PPV | NPV |
|---|---|---|---|---|
| 0.9 | 0.96 | 0.82 | 0.98 | |
| 0.8 | 0.95 | 0.76 | 0.96 | |
| 0.9 | 0.91 | 0.67 | 0.98 | |
| 0.6 | 0.99 | 0.92 | 0.93 | |
| 0.85 | 0.94 | 0.74 | 0.97 | |
| 0.55 | 0.98 | 0.85 | 0.92 |
PPV positive predictive value, NPV negative predictive value
Fig. 5Distribution and relative abundance of microbial genera in saliva, oral rinse and other sites. a Comparison of mean values detected in saliva, oral rinse, and other sites (hard and soft tissues). Hierarchical legend is also shown. b Comparison of mean relative abundance values detected in saliva, oral rinse and other sites (hard and soft tissues)
Fig. 6Characterization of the HOM resistome, as detected by qPCR microarray analysis. a HOM resistome in the whole study group. b Comparison of HOM resistomes of female (F) and male (M) study participants. I both panels the results are expressed as the mean value ± SD of Log10 fold change of oral rinse samples compared to negative controls, for each indicated resistance gene